nsg7010 week 3 reply to discussion post

Post #1 Lisbeth.  For this reason, the statistical data it provides serves as feedback to design better health interventions. The Food and Drug Administration (FDA) also helps improve information on health disparities. This fact has been demonstrated through developing clinical trials to approve new medications and devices (Darrow et al., 2020). In this sense, I am a sub-investigator at a medical center in Florida. We are conducting many clinical trials in different chronic diseases. These clinical trials also allow the collection of demographic and social information to more adequately describe the characteristics of individuals with acute and chronic diseases. This information would be helpful to engage in policy discussions with our legislators. Nurses and health professionals must be more involved in political decisions. Our contribution to developing better health policies is crucial to increasing the quality of life in our communities. 

Post #2 Steven, The Department of Health and Human Services created the Office of Minority Health (OMH) in 2010 and consists of AHRQ, CDC, CMS, FDA, HRSA, and SAMHSA. The goal of this alliance is to reduce or eliminate healthcare disparities amongst racial and ethnic minorities (U.S. Department of Health and Human Services Office of Minority Health [OMH], 2023). Health disparities are well documented in the United States, and it is critical to examine not only different groups but also subgroups within the groups (Field & Reingle Gonzalez, 2022). The organizations included in the Office of Minority Health provide needed research and statistics that could be used during correspondence with legislatures. There is no doubt that there is a lot of work that still needs to be done in this country.